| scholarly article | Q13442814 |
| P50 | author | Brandon Keele | Q68690678 |
| P2093 | author name string | Christine M. Fennessey | |
| P2860 | cites work | Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 |
| HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC | Q21559422 | ||
| Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
| Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies | Q28307869 | ||
| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial | Q29619176 | ||
| Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial | Q29619179 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial | Q30532861 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins | Q33494829 | ||
| Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination | Q33582077 | ||
| High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. | Q33582135 | ||
| Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis | Q33592278 | ||
| Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing | Q33680395 | ||
| Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment | Q33782843 | ||
| Wide variation in the multiplicity of HIV-1 infection among injection drug users | Q33877419 | ||
| A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. | Q33966648 | ||
| A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity | Q34005516 | ||
| Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure | Q36667917 | ||
| Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus | Q36674033 | ||
| Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies | Q36760147 | ||
| Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques | Q36760165 | ||
| Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection | Q36949811 | ||
| Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge | Q37067177 | ||
| Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. | Q37110723 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge | Q37232824 | ||
| Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge | Q37287080 | ||
| Modeling sequence evolution in acute HIV-1 infection | Q37384535 | ||
| A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system | Q37829628 | ||
| HIV vaccine development at the turn of the 21st century | Q37966756 | ||
| Animal models of antiretroviral prophylaxis for HIV prevention | Q38042299 | ||
| A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia | Q45871436 | ||
| Preventing sexual transmission of HIV | Q80481726 | ||
| Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections | Q34042642 | ||
| Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys | Q34120840 | ||
| Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody | Q34630446 | ||
| Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis | Q34804928 | ||
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia | Q34848486 | ||
| Glycerol monolaurate prevents mucosal SIV transmission | Q34957016 | ||
| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine | Q35009558 | ||
| Barriers to mucosal transmission of immunodeficiency viruses | Q35140968 | ||
| The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine | Q35200862 | ||
| The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys | Q35382944 | ||
| TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure | Q35531415 | ||
| SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma | Q35581949 | ||
| Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue | Q35665851 | ||
| Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys | Q35729899 | ||
| The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study | Q35742086 | ||
| SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses | Q35754196 | ||
| HIV prevention by oral preexposure prophylaxis | Q35765743 | ||
| Expression of structural proteins in human female and male genital epithelia and implications for sexually transmitted infections | Q35790984 | ||
| Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages | Q35826158 | ||
| Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va | Q35826525 | ||
| Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac2 | Q35867976 | ||
| Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape | Q36000736 | ||
| A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge | Q36024470 | ||
| Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys | Q36155555 | ||
| Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis | Q36299730 | ||
| Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome | Q36394656 | ||
| Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection | Q36516875 | ||
| HIV transmission | Q36526615 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Impact of mucosal inflammation on oral simian immunodeficiency virus transmission | Q36559896 | ||
| Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques. | Q36604359 | ||
| Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques | Q36628606 | ||
| DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge | Q36637349 | ||
| Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS | Q36667821 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV transmission | Q49029021 |
| P304 | page(s) | 280-7 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Current Opinion in HIV and AIDS | Q15724409 |
| P1476 | title | Using nonhuman primates to model HIV transmission | |
| P478 | volume | 8 |
| Q39481098 | B Cell Responses Associated with Vaccine-Induced Delayed SIVmac251 Acquisition in Female Rhesus Macaques |
| Q98735530 | Characterization of Rhesus Macaque Liver-Resident CD49a+ NK Cells During Retrovirus Infections |
| Q37716218 | Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing |
| Q33602718 | Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild |
| Q59357086 | Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV |
| Q35748138 | Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides |
| Q35794988 | HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model |
| Q36269097 | HIV transmission biology: translation for HIV prevention |
| Q38918138 | Imaging lymphoid tissues in nonhuman primates to understand SIV pathogenesis and persistence |
| Q90616717 | In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses |
| Q37208031 | Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaques |
| Q35776556 | Macaque models of enhanced susceptibility to HIV. |
| Q59358396 | Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques |
| Q33900353 | Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events |
| Q59350268 | Nonhuman primate models of human viral infections |
| Q38849453 | Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection |
| Q92736069 | T Cells in the Female Reproductive Tract Can Both Block and Facilitate HIV Transmission |
| Q60307880 | Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge |
Search more.